AB
AVIR icon

Amalgamated Bank’s Atea Pharmaceuticals AVIR Stock Holding History

Amalgamated Bank’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,233
Closed -$8K – 1733
2025
Q4 		$8K Sell
2,233
-440
-16% -$1.4K ﹤0.01% 2499
2025
Q3 		$8K Hold
2,673
– – ﹤0.01% 2548
2025
Q2 		$10K Hold
2,673
– – ﹤0.01% 2422
2025
Q1 		$8K Hold
2,673
– – ﹤0.01% 2455
2024
Q4 		$9K Hold
2,673
– – ﹤0.01% 2463
2024
Q3 		$9K Hold
2,673
– – ﹤0.01% 2484
2024
Q2 		$9K Hold
2,673
– – ﹤0.01% 2486
2024
Q1 		$11K Sell
2,673
-4,102
-61% -$16.1K ﹤0.01% 2382
2023
Q4 		$21K Sell
6,775
-795
-11% -$2.41K ﹤0.01% 2617
2023
Q3 		$23K Hold
7,570
– – ﹤0.01% 2572
2023
Q2 		$28K Sell
7,570
-357
-5% -$1.34K ﹤0.01% 2563
2023
Q1 		$27K Sell
7,927
-1,769
-18% -$7.18K ﹤0.01% 2530
2022
Q4 		$47K Hold
9,696
– – ﹤0.01% 2434
2022
Q3 		$55K Hold
9,696
– – ﹤0.01% 2411
2022
Q2 		$69K Buy
9,696
+1,616
+20% +$11K ﹤0.01% 2326
2022
Q1 		$58K Buy
+8,080
New +$54.9K ﹤0.01% 2401
2021
Q4 		– Sell
-8,773
Closed -$308K – 2164
2021
Q3 		$308K Sell
8,773
-580
-6% -$16.1K ﹤0.01% 1831
2021
Q2 		$201K Buy
+9,353
New +$281K ﹤0.01% 2027

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Amalgamated Bank's AVIR Position: Q1 2026 in Review

Amalgamated Bank sold out of Atea Pharmaceuticals (AVIR) in Q1 2026, closing a stake of 2,233 shares — an estimated $8K sold.

Amalgamated Bank first reported a position in AVIR in Q2 2021 and held it in 18 quarters. The position peaked at $308K in Q3 2021. 127 funds tracked by Wall St. Rank hold AVIR as of Q1 2026.

  • Amalgamated Bank reported no remaining Atea Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 2,233 Atea Pharmaceuticals shares in Q1 2026, an estimated $8K.
  • Amalgamated Bank first reported a position in Atea Pharmaceuticals in Q2 2021 and held it in 18 quarters.
  • Amalgamated Bank's Atea Pharmaceuticals position peaked at $308K in Q3 2021.
  • 127 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.